American Research & Management Company’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$206K Sell
3,606
-80
-2% -$4.66K 0.06% 117
2022
Q2
$200K Sell
3,686
-312
-8% -$18.1K 0.05% 123
2022
Q1
$230K Hold
3,998
0.05% 123
2021
Q4
$189K Buy
3,998
+29
+0.7% +$1.32K 0.04% 134
2021
Q3
$167K Hold
3,969
0.04% 138
2021
Q2
$176K Hold
3,969
0.04% 136
2021
Q1
$185K Sell
3,969
-91
-2% -$4.03K 0.04% 129
2020
Q4
$157K Hold
4,060
0.04% 138
2020
Q3
$117K Sell
4,060
-1,638
-29% -$46.1K 0.03% 135
2020
Q2
$153K Hold
5,698
0.05% 129
2020
Q1
$134K Sell
5,698
-388
-6% -$10.7K 0.05% 127
2019
Q4
$180K Sell
6,086
-1,266
-17% -$33.5K 0.05% 129
2019
Q3
$206K Sell
7,352
-3,118
-30% -$90.1K 0.06% 127
2019
Q2
$310K Buy
+10,470
New +$282K 0.09% 119

Other funds holding CTVA

American Research & Management Company's CTVA Position: Q3 2022 in Review

American Research & Management Company reduced its Corteva (CTVA) stake by 2.2% in Q3 2022, selling an estimated $4.66K and leaving 3,606 shares worth $206K. The position accounts for 0.06% of the portfolio, ranked #117.

American Research & Management Company first reported a position in CTVA in Q2 2019 and has held it in 14 quarters since. The position peaked at $310K in Q2 2019. 1,225 funds tracked by Wall St. Rank hold CTVA as of Q3 2022.

  • American Research & Management Company held 3,606 shares of Corteva worth $206K as of Q3 2022.
  • American Research & Management Company sold 80 Corteva shares in Q3 2022, an estimated $4.66K.
  • Corteva made up 0.06% of American Research & Management Company's portfolio in Q3 2022, its #117 holding.
  • American Research & Management Company first reported a position in Corteva in Q2 2019 and has held it in 14 quarters since.
  • American Research & Management Company's Corteva position peaked at $310K in Q2 2019.
  • 1,225 funds tracked by Wall St. Rank held Corteva as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.